Hifibio Inc.

Hifibio Inc., operating through Hifibio Clinical in Cambridge, focuses its clinical research activity on advanced solid tumors, with studies spanning a range of advanced cancers of different organs. Its trial portfolio centers on treatment approaches for patients with difficult-to-treat malignant disease.

• Solid tumor oncology
• Advanced cancer across multiple organs
• Adult cancer care

The sponsor’s active research is directed toward therapeutic areas in which oncology remains a major unmet need, with ongoing studies involving both single-agent and combination treatment strategies.